Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for PBH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 47.37M
March 31, 2026 47.32M
December 31, 2025 47.32M
September 30, 2025 48.08M
June 30, 2025 49.21M
March 31, 2025 49.51M
December 31, 2024 49.58M
September 30, 2024 49.44M
June 30, 2024 49.55M
March 31, 2024 49.82M
December 31, 2023 49.65M
September 30, 2023 49.61M
June 30, 2023 49.54M
March 31, 2023 49.69M
December 31, 2022 49.69M
September 30, 2022 49.53M
June 30, 2022 49.76M
March 31, 2022 50.28M
December 31, 2021 50.20M
September 30, 2021 50.10M
June 30, 2021 50.06M
March 31, 2021 49.91M
December 31, 2020 53.94M
September 30, 2020 50.16M
June 30, 2020 50.19M
Date Value
March 31, 2020 50.09M
December 31, 2019 50.25M
September 30, 2019 50.23M
June 30, 2019 50.89M
March 31, 2019 51.80M
December 31, 2018 53.67M
September 30, 2018 53.61M
June 30, 2018 51.73M
March 31, 2018 53.04M
December 31, 2017 53.04M
September 30, 2017 53.04M
June 30, 2017 53.00M
March 31, 2017 52.96M
December 31, 2016 52.94M
September 30, 2016 52.93M
June 30, 2016 52.92M
March 31, 2016 52.76M
December 31, 2015 52.75M
September 30, 2015 52.75M
June 30, 2015 52.73M
March 31, 2015 52.30M
December 31, 2014 52.25M
September 30, 2014 52.17M
June 30, 2014 51.97M
March 31, 2014 51.82M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Indivior Pharmaceuticals, Inc. 118.00M
ANI Pharmaceuticals, Inc. 22.97M
Corcept Therapeutics, Inc. 107.92M
Veru, Inc. 17.05M
Johnson & Johnson 2.408B